10 Years Closer to the Finish. Welcome to the 10th Annual National Marathon to Finish Breast Cancer.
DONNA Marathon Weekend welcomes thousands of runners and supporters from all over the world February 10 – 12, 2017. As the only marathon in the U.S. dedicated to breast cancer research and care, experience a course unlike any other with a beach community to match.
The Anniversary weekend kicks off with the opening of the DONNA Expo presented by SMG & The City of Jacksonville on Friday, February 10 at Noon in Downtown Jacksonville, Florida. Don’t miss the NEW Anniversary 10K for Metastatic Breast Cancer sponsored by Pfizer and the DONNA 5K & Family Fun Run presented by Jaguars Foundation Saturday, February 11.
Marathon races begin at 7:30 a.m. on Sunday, February 12 at the Celgene Start Line near THE PLAYERS Parking Lot off ATP Tour Boulevard in Ponte Vedra Beach, Florida. Runners will begin along historic coastal A1A, and meander through the unique beach communities of Ponte Vedra Beach, Jacksonville Beach, Neptune Beach and Atlantic Beach. Panoramic views of the intracoastal waterway and tidal marshland welcome runners to finish the race, and breast cancer, at Mayo Clinic.
DONNA Marathon Weekend is an official event of The DONNA Foundation. A non-profit organization based on Northeast Florida, The DONNA Foundation provides financial assistance and support to families living with breast cancer and funds ground breaking breast cancer research. Since the inaugural marathon weekend in 2008, The DONNA Foundation has dispersed $5 million of race proceeds toward its mission to finish breast cancer.
To date, The DONNA Foundation has served more than 10,000 families. The DONNA Foundation also helped to develop and maintain the Mayo Clinic Breast Cancer Translational Genomics Program. Ongoing funding from the foundation make it possible for the laboratory team not only to conduct state of the art breast cancer research, including the widely publicized Triple Negative Breast Cancer Vaccine Trials, but also provide genomics support for studies in all cancers.